The presence of skin lesions has previously been associated with other EGFR inhibitors and the consequence of exaggerated pharmacology may result in the adverse skin reaction seen in the rat.
The presence of skin lesions has previously been associated with other EGFR inhibitors and the consequence of exaggerated pharmacology may result in the adverse skin reaction seen in the rat.